MADRIGAL PHARMACEUTICALS, INC. Operating Income
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Operating Income of -$56.31 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-30
- MADRIGAL PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$56.31M.
- MADRIGAL PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$92.72M.
- MADRIGAL PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$59.61M.
- MADRIGAL PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$113.97M.
- MADRIGAL PHARMACEUTICALS, INC. operating income (loss) for fiscal 2025 was -$300.10M.
- MADRIGAL PHARMACEUTICALS, INC. operating income (loss) for fiscal 2024 was -$497.88M.
- MADRIGAL PHARMACEUTICALS, INC. operating income (loss) for fiscal 2023 was -$380.50M.
- MADRIGAL PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$293.57M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$56.31M 10-Q · filed 2026-07-30 | -$149.03M 10-Q · filed 2026-07-30 | -$208.64M derived: sum of 3 quarters · filed 2026-07-30 | -$322.62M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | -$92.72M 10-Q · filed 2026-05-06 | -$152.33M derived: sum of 2 quarters · filed 2026-05-06 | -$266.31M derived: sum of 3 quarters · filed 2026-05-06 | -$313.51M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$59.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$173.58M derived: sum of 2 quarters · filed 2026-02-19 | -$220.79M derived: sum of 3 quarters · filed 2026-07-30 | -$300.10M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | -$113.97M 10-Q · filed 2025-11-04 | -$161.18M derived: sum of 2 quarters · filed 2026-07-30 | -$240.49M 10-Q · filed 2025-11-04 | -$307.48M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$47.20M 10-Q · filed 2026-07-30 | -$126.51M 10-Q · filed 2026-07-30 | -$193.51M derived: sum of 3 quarters · filed 2026-07-30 | -$309.81M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | -$79.31M 10-Q · filed 2026-05-06 | -$146.31M derived: sum of 2 quarters · filed 2026-05-06 | -$262.61M derived: sum of 3 quarters · filed 2026-05-06 | -$425.15M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$183.30M derived: sum of 2 quarters · filed 2026-02-19 | -$345.84M derived: sum of 3 quarters · filed 2026-02-19 | -$497.88M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | -$116.30M 10-Q · filed 2025-11-04 | -$278.84M derived: sum of 2 quarters · filed 2025-11-04 | -$430.88M 10-Q · filed 2025-11-04 | -$548.05M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | -$162.54M 10-Q · filed 2025-08-05 | -$314.57M 10-Q · filed 2025-08-05 | -$431.75M derived: sum of 3 quarters · filed 2025-08-05 | -$530.28M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$152.04M 10-Q · filed 2025-05-01 | -$269.21M derived: sum of 2 quarters · filed 2025-05-01 | -$367.75M derived: sum of 3 quarters · filed 2025-05-01 | -$454.20M derived: sum of 4 quarters · filed 2025-05-01 | ||||
| 2023-12-31 | -$117.18M 10-K · filed 2024-02-28 | -$215.71M derived: sum of 2 quarters · filed 2024-10-31 | -$302.16M derived: sum of 3 quarters · filed 2024-10-31 | -$380.50M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | -$98.53M 10-Q · filed 2024-10-31 | -$184.98M derived: sum of 2 quarters · filed 2024-10-31 | -$263.32M 10-Q · filed 2024-10-31 | -$348.62M derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | -$86.45M 10-Q · filed 2024-08-07 | -$164.79M 10-Q · filed 2024-08-07 | -$250.09M derived: sum of 3 quarters · filed 2024-08-07 | -$330.50M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | -$78.34M 10-Q · filed 2024-05-07 | -$163.63M derived: sum of 2 quarters · filed 2024-05-07 | -$244.05M derived: sum of 3 quarters · filed 2024-05-07 | -$314.32M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$85.30M 10-K · filed 2024-02-28 | -$165.71M derived: sum of 2 quarters · filed 2024-02-28 | -$235.98M derived: sum of 3 quarters · filed 2024-02-28 | -$293.57M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | -$80.41M 10-K · filed 2024-02-28 | -$150.69M derived: sum of 2 quarters · filed 2024-02-28 | -$208.27M 10-Q · filed 2023-11-06 | -$272.87M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | -$70.27M 10-K · filed 2024-02-28 | -$127.86M 10-Q · filed 2023-08-08 | -$192.46M derived: sum of 3 quarters · filed 2024-02-28 | -$255.62M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | -$57.59M 10-K · filed 2024-02-28 | -$122.19M derived: sum of 2 quarters · filed 2024-02-28 | -$185.35M derived: sum of 3 quarters · filed 2024-02-28 | -$247.09M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$64.60M 10-K/A · filed 2023-03-03 | -$127.76M derived: sum of 2 quarters · filed 2023-03-03 | -$189.50M derived: sum of 3 quarters · filed 2023-03-03 | -$242.48M 10-K · filed 2024-02-28 | ||||
| 2021-09-30 | -$63.16M 10-K/A · filed 2023-03-03 | -$124.90M derived: sum of 2 quarters · filed 2023-03-03 | -$177.88M 10-Q · filed 2022-11-03 | -$237.44M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-06-30 | -$61.74M 10-K/A · filed 2023-03-03 | -$114.72M 10-Q · filed 2022-08-04 | -$174.28M derived: sum of 3 quarters · filed 2023-03-03 | -$233.06M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-31 | -$52.98M 10-K/A · filed 2023-03-03 | -$112.53M derived: sum of 2 quarters · filed 2023-03-03 | -$171.32M derived: sum of 3 quarters · filed 2023-03-03 | -$221.65M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | -$59.55M 10-K · filed 2022-02-24 | -$118.34M derived: sum of 2 quarters · filed 2022-02-24 | -$168.67M derived: sum of 3 quarters · filed 2022-02-24 | -$206.67M 10-K/A · filed 2023-03-03 | ||||
| 2020-09-30 | -$58.79M 10-K · filed 2022-02-24 | -$109.11M derived: sum of 2 quarters · filed 2022-02-24 | -$147.12M 10-Q · filed 2021-11-04 | -$177.07M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-06-30 | -$50.33M 10-K · filed 2022-02-24 | -$88.33M 10-Q · filed 2021-08-05 | -$118.29M derived: sum of 3 quarters · filed 2022-02-24 | -$142.48M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2020-03-31 | -$38.01M 10-K · filed 2022-02-24 | -$67.96M derived: sum of 2 quarters · filed 2022-02-24 | -$92.15M derived: sum of 3 quarters · filed 2022-02-24 | -$114.86M derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | -$29.95M 10-K · filed 2021-02-25 | -$54.15M derived: sum of 2 quarters · filed 2021-02-25 | -$76.85M derived: sum of 3 quarters · filed 2021-02-25 | -$94.97M 10-K · filed 2022-02-24 | ||||
| 2019-09-30 | -$24.20M 10-K · filed 2021-02-25 | -$46.90M derived: sum of 2 quarters · filed 2021-02-25 | -$65.02M 10-Q · filed 2020-11-05 | -$79.47M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$22.70M 10-K · filed 2021-02-25 | -$40.82M 10-Q · filed 2020-08-06 | -$55.28M derived: sum of 3 quarters · filed 2021-02-25 | -$66.61M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$18.12M 10-K · filed 2021-02-25 | -$32.57M derived: sum of 2 quarters · filed 2021-02-25 | -$43.91M derived: sum of 3 quarters · filed 2021-02-25 | -$51.73M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$14.45M 10-K · filed 2020-02-26 | -$25.79M derived: sum of 2 quarters · filed 2020-02-26 | -$33.61M derived: sum of 3 quarters · filed 2020-02-26 | -$40.68M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$11.33M 10-K · filed 2020-02-26 | -$19.16M derived: sum of 2 quarters · filed 2020-02-26 | -$26.23M 10-Q · filed 2019-11-06 | -$35.14M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-06-30 | -$7.83M 10-K · filed 2020-02-26 | -$14.89M 10-Q · filed 2019-08-07 | -$23.81M derived: sum of 3 quarters · filed 2020-02-26 | -$32.44M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2018-03-31 | -$7.07M 10-K · filed 2020-02-26 | -$15.98M derived: sum of 2 quarters · filed 2020-02-26 | -$24.62M derived: sum of 3 quarters · filed 2020-02-26 | -$33.06M derived: sum of 4 quarters · filed 2020-02-26 | ||||
| 2017-12-31 | -$8.91M 10-K · filed 2019-02-27 | -$17.55M derived: sum of 2 quarters · filed 2019-02-27 | -$25.99M derived: sum of 3 quarters · filed 2019-02-27 | -$32.06M 10-K · filed 2020-02-26 | ||||
| 2017-09-30 | -$8.64M 10-K · filed 2019-02-27 | -$17.08M derived: sum of 2 quarters · filed 2019-02-27 | -$23.15M 10-Q · filed 2018-11-06 | -$30.91M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | -$8.44M 10-K · filed 2019-02-27 | -$14.51M 10-Q · filed 2018-08-07 | -$22.27M derived: sum of 3 quarters · filed 2019-02-27 | -$36.36M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | -$6.08M 10-K · filed 2019-02-27 | -$13.83M derived: sum of 2 quarters · filed 2019-02-27 | -$27.92M derived: sum of 3 quarters · filed 2019-02-27 | -$30.56M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | -$7.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$21.85M derived: sum of 2 quarters · filed 2019-02-27 | -$24.48M derived: sum of 3 quarters · filed 2019-02-27 | -$25.22M 10-K · filed 2019-02-27 | -$25.22M 10-K · filed 2017-03-31 | |||
| 2016-09-30 | -$14.09M 10-Q · filed 2017-11-09 | -$14.09M 10-Q · filed 2016-11-14 | -$16.73M derived: sum of 2 quarters · filed 2017-11-09 | -$17.47M 10-Q · filed 2017-11-09 | -$17.47M 10-Q · filed 2016-11-14 | -$27.85M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | -$2.64M 10-Q · filed 2017-08-10 | -$3.49M 10-Q · filed 2016-07-20 | -$3.38M 10-Q · filed 2017-08-10 | -$9.94M 10-Q · filed 2016-07-20 | -$13.76M derived: sum of 3 quarters · filed 2017-08-10 | -$14.64M derived: sum of 4 quarters · filed 2017-08-10 | ||
| 2016-03-31 | -$738.00K 10-Q · filed 2017-05-11 | -$6.45M 10-Q · filed 2016-05-10 | -$11.12M derived: sum of 2 quarters · filed 2017-05-11 | -$12.00M derived: sum of 3 quarters · filed 2017-05-11 | -$31.50M derived: sum of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -$10.38M 10-K · filed 2016-03-15 | -$11.26M derived: sum of 2 quarters · filed 2017-03-31 | -$30.76M derived: sum of 3 quarters · filed 2017-03-31 | -$3.23M 10-K · filed 2017-03-31 | -$67.61M 10-K · filed 2016-03-15 | |||
| 2015-09-30 | -$880.03K 10-Q/A · filed 2017-03-31 | -$17.39M 10-Q · filed 2015-11-05 | -$20.38M derived: sum of 2 quarters · filed 2017-03-31 | -$2.31M 10-Q/A · filed 2017-03-31 | -$57.23M 10-Q · filed 2015-11-05 | -$60.61M derived: sum of 4 quarters · filed 2017-03-31 | ||
| 2015-06-30 | -$19.50M 10-Q · filed 2016-07-20 | -$39.84M 10-Q · filed 2016-07-20 | -$59.73M derived: sum of 3 quarters · filed 2016-07-20 | -$79.18M derived: sum of 4 quarters · filed 2016-07-20 | ||||
| 2015-03-31 | -$20.33M 10-Q · filed 2016-05-10 | -$40.23M derived: sum of 2 quarters · filed 2016-05-10 | -$59.67M derived: sum of 3 quarters · filed 2016-05-10 | -$81.38M derived: sum of 4 quarters · filed 2016-05-10 | ||||
| 2014-12-31 | -$19.89M 10-K · filed 2016-03-15 | -$39.34M derived: sum of 2 quarters · filed 2016-03-15 | -$61.04M derived: sum of 3 quarters · filed 2016-03-15 | -$83.95M 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | -$19.45M 10-K · filed 2016-03-15 | -$41.15M derived: sum of 2 quarters · filed 2016-03-15 | -$64.06M 10-Q · filed 2015-11-05 | -$87.50M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | -$21.70M 10-K · filed 2016-03-15 | -$44.61M 10-Q · filed 2015-08-06 | -$68.05M derived: sum of 3 quarters · filed 2016-03-15 | -$89.85M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | -$22.91M 10-K · filed 2016-03-15 | -$46.35M derived: sum of 2 quarters · filed 2016-03-15 | -$68.14M derived: sum of 3 quarters · filed 2016-03-15 | -$90.21M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | -$23.44M 10-K · filed 2015-03-12 | -$45.24M derived: sum of 2 quarters · filed 2015-03-12 | -$67.30M derived: sum of 3 quarters · filed 2015-03-12 | -$87.56M 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | -$21.79M 10-K · filed 2015-03-12 | -$43.86M derived: sum of 2 quarters · filed 2015-03-12 | -$64.11M 10-Q · filed 2014-11-06 | -$81.82M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | -$22.06M 10-K · filed 2015-03-12 | -$42.32M 10-Q · filed 2014-08-06 | -$60.02M derived: sum of 3 quarters · filed 2015-03-12 | -$74.56M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | -$20.26M 10-K · filed 2015-03-12 | -$37.96M derived: sum of 2 quarters · filed 2015-03-12 | -$52.50M derived: sum of 3 quarters · filed 2015-03-12 | -$66.63M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | -$17.70M 10-K · filed 2014-03-11 | -$32.24M derived: sum of 2 quarters · filed 2014-03-11 | -$46.38M derived: sum of 3 quarters · filed 2014-03-11 | -$60.94M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | -$14.54M 10-K · filed 2014-03-11 | -$28.67M derived: sum of 2 quarters · filed 2014-03-11 | -$43.24M 10-Q · filed 2013-11-04 | -$53.48M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | -$14.13M 10-K · filed 2014-03-11 | -$28.70M 10-Q · filed 2013-08-01 | -$38.94M derived: sum of 3 quarters · filed 2014-03-11 | -$51.16M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | -$14.56M 10-K · filed 2014-03-11 | -$24.80M derived: sum of 2 quarters · filed 2014-03-11 | -$37.02M derived: sum of 3 quarters · filed 2014-03-11 | -$49.03M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2011-12-31 | -$10.24M 10-K · filed 2013-03-14 | -$22.46M derived: sum of 2 quarters · filed 2013-03-14 | -$34.47M derived: sum of 3 quarters · filed 2013-03-14 | -$45.43M 10-K · filed 2014-03-11 | ||||
| 2011-09-30 | -$12.22M 10-K · filed 2013-03-14 | -$24.23M derived: sum of 2 quarters · filed 2013-03-14 | -$35.19M 10-Q · filed 2012-11-06 | -$43.56M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-06-30 | -$12.01M 10-K · filed 2013-03-14 | -$22.98M 10-Q · filed 2012-08-02 | -$31.34M derived: sum of 3 quarters · filed 2013-03-14 | -$41.57M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2011-03-31 | -$10.97M 10-K · filed 2013-03-14 | -$19.33M derived: sum of 2 quarters · filed 2013-03-14 | -$29.56M derived: sum of 3 quarters · filed 2013-03-14 | -$38.61M derived: sum of 4 quarters · filed 2013-03-14 | ||||
| 2010-12-31 | -$8.37M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | -$18.60M derived: sum of 2 quarters · filed 2013-03-14 | -$27.64M derived: sum of 3 quarters · filed 2013-03-14 | -$36.90M 10-K · filed 2013-03-14 | ||||
| 2010-09-30 | -$10.23M 10-Q · filed 2011-11-03 | -$19.27M derived: sum of 2 quarters · filed 2011-11-03 | -$28.53M 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | -$9.04M 10-Q · filed 2011-08-04 | -$18.30M 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | $79.30M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |